Ascentage Pharma

NCT02935907

APG-115 in Patients With Advanced Solid Tumors or Lymphomas

NCT03080311

A Study of APG-1252 in Patients With SCLC or Other Solid Tumors

NCT03386526

APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies

NCT03387332

APG-1252 in Patients With SCLC or Advanced Solid Tumors

NCT03585322

APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B

NCT03594422

A Study of HQP1351 in Patients With GIST or Other Solid Tumors

NCT03882281

Pharmacokinetics Profiles of HQP1351 Under Fasting and High-fat Meals in Patients With Chronic Myeloid Leukemia

NCT03917043

APG-2449 in Patients With Advanced Solid Tumors

NCT03913949

A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies

NCT04001777

A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC Patients

NCT04126707

The Absorption, Metabolism and Excretion of [14C] HQP1351 in Humans

NCT04260022

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

NCT04215809

Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL

NCT04275518

A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.

NCT04260217

APG-2575 Single Agent or in Combination With Ibrutinib or Rituximab in Patients With Waldenström Macroglobulinemia

NCT04893759

A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors

NCT05517616

The Absorption, Metabolism and Excretion of [14C]APG-2575 in Healthy Subjects

NCT05415098

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

NCT05701306

APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors

NCT05773586

A Study to Investigate the Safety, Pharmacokinetics and Efficacy of APG-5918 in Healthy Subjects or Anemic Patients

NCT06401603

A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia

NCT06687070

APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST